Policondrite recidivante: prevalência de doenças cardiovasculares e seus fatores de risco e características gerais da doença de acordo com o gênero

Revista Brasileira de Reumatologia - Tập 57 - Trang 338-345 - 2017
Pablo Arturo Olivo Pallo1, Maurício Levy‐Neto1, Rosa Maria Rodrigues Pereira2, Samuel Katsuyuki Shinjo2
1Universidade de São Paulo, Faculdade de Medicina, Hospital das Clínicas HCFMUSP, São Paulo, SP, Brasil
2Universidade de São Paulo, Faculdade de Medicina, Disciplina de Reumatologia, São Paulo, SP, Brasil

Tài liệu tham khảo

Sharma, 2013, Relapsing polychondritis: a review, Clin Rheumatol, 32, 1575, 10.1007/s10067-013-2328-x Gergely, 2004, Relapsing polychondritis, Best Pract Res Clin Rheumatol, 18, 723, 10.1016/j.berh.2004.05.012 Ananthakrishna, 2009, Relapsing polycondritis – Case series from South India, Clin Rheumatol, 28, S7, 10.1007/s10067-008-1016-8 Kent, 2004, Relapsing polychondritis, Curr Opin Rheumatol, 16, 56, 10.1097/00002281-200401000-00011 Peebo, 2004, Relapsing polychondritis: a rare disease with varying symptoms, Acta Ophthalmol Scand, 82, 472, 10.1111/j.1600-0420.2004.00276.x McAdam, 1976, Relapsing polychondritis: prospective study of 23 patients and a review of the literature, Medicine (Baltimore), 55, 193, 10.1097/00005792-197605000-00001 Michel, 1986, Relapsing polychondritis: survival and predictive role of early disease manifestations, Ann Intern Med, 104, 74, 10.7326/0003-4819-104-1-74 Chang-Miller, 1987, Renal involvement in relapsing polychondritis, Medicine (Baltimore), 66, 202, 10.1097/00005792-198705000-00004 Zeuner, 1997, Relapsing polychondritis: clinical and immunogenetic analysis of 62 patients, J Rheumatol, 24, 96 Trentham, 1998, Relapsing polychondritis, Ann Intern Med, 129, 114, 10.7326/0003-4819-129-2-199807150-00011 Hazra, 2015, Incidence and mortality of relapsing polychondritis in the UK: a population‐based cohort study, Rheumatology, 54, 2181 Lin, 2016, Clinical and prognostic characteristics of 158 cases of relapsing polychondritis in China and review of the literature, Rheumatol Int, 36, 1003, 10.1007/s00296-016-3449-8 Shimuzu, 2016, Cutaneos manifestations of patients with relapsing polychondritis: an association with extracutaneous complications, Clin Rheumatol, 35, 781, 10.1007/s10067-015-3160-2 De Backer, 2003, Eur Heart J, 24, 1601, 10.1016/S0195-668X(03)00347-6 1997, The Expert Committee on the diagnosis and classification of diabetes mellitus. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus, Diabetes Care, 20, 1183, 10.2337/diacare.20.7.1183 Movahedi, 2016, Risk of incident diabetes mellitus associated with the dosage and duration of oral glucocorticoid therapy in patients with rheumatoid arthritis, Arthritis Rheumatol, 68, 1089 Di Dalmazi, 2012, Glucocorticoids and type 2 diabetes, from physiopatology, J Nutr Metab, 2012, 525093, 10.1155/2012/525093 Walker, 1994, New mechanisms for corticosteroid‐induced hypertension, Br Med Bull, 50, 342, 10.1093/oxfordjournals.bmb.a072895 de Moraes, 2013, Analysis of metabolic síndrome in adult dermatomyositis with a focus on cardiovascular disesase, Arthritis Care Res, 65, 793, 10.1002/acr.21879 de Souza, 2014, The high prevalence of metabolic syndrome in polymyositis, Clin Exp Rheumatol, 32, 82 Pereira, 2009, Metabolic syndrome in rheumatological diseases, Autoimmun Rev, 8, 415, 10.1016/j.autrev.2009.01.001 Bruce, 2005, ‘Not only, but also’: factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus, Rheumatology (Oxford), 44, 1492, 10.1093/rheumatology/kei142 Aviña-Zubieta, 2008, Risk of cardiovascular mortality in patients with rheumatoid arthritis: a metaanalysis of observational studies, Arthritis Rheum, 59, 1690, 10.1002/art.24092 Peters, 2004, Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis, Semin Arthritis Rheum, 34, 585, 10.1016/j.semarthrit.2004.07.010 Coulson, 2013, Cardiovascular risk in juvenile idiopathic arthritis, Rheumatology (Oxford), 52, 1163, 10.1093/rheumatology/ket106 Lahmer, 2010, Relapsing polychondritis: an autoimmune disease with many faces, Autoimmun Rev, 9, 950, 10.1016/j.autrev.2010.02.016 Isaak, 1986, Ocular and systemic findings in relapsing polychondritis, Ophthalmology, 93, 681, 10.1016/S0161-6420(86)33695-9 Yu, 2006, Obliterative microangiopathy presenting as chronic conjunctivitis in a patient with relapsing polychondritis, Cornea, 25, 621, 10.1097/01.ico.0000227886.26747.a9 Chow, 2000, Relapsing polychondritis, Optom Vis Sci, 77, 286, 10.1097/00006324-200006000-00008 Letko, 2002, Relapsing polychondritis: a clinical review, Semin Arthritis Rheum, 31, 384, 10.1053/sarh.2002.32586 Bachor, 2006, Otologic manifestations of relapsing polychondritis. Review of literatura and report of nine cases, Auris Nasus Larynx, 33, 135, 10.1016/j.anl.2005.11.020 Suzuki, 2015, Fever and cough without pulmonary abnormalities on CT: relapsing polychondritis restricted to the airways, Lancet, 385, 88, 10.1016/S0140-6736(14)61946-2 Adliff, 1997, Treatment of diffuse tracheomalacia secondary to relapsing polychondritis with continuous positive airway pressure, Chest, 112, 1701, 10.1378/chest.112.6.1701 Lee, 2006, Prevalence of functional airway abnormalities in relapsing polychondritis, Radiology, 240, 565, 10.1148/radiol.2401050562